Articles
Insights
Insights That Move Specialty Care Forward
Featured Insights
Integrated Specialty Care
Driving Better Hemophilia Outcomes Through Integrated Care
Explore All Insights
-
Beyond Weight Loss: Optimizing GLP-1 RA Therapy for Older Adults Using the Medicare Bridge Program
-
Shields PGY1 Community-Based Residency Programs
Articles
Shields PGY1 Community-Based Residency Programs
Launch Your Specialty Pharmacy Career with Expert Mentorship and Real-World Experience
-
Revised 340B Rebate Model Pilot Program: What Covered Entities Need to Know for 2027
Articles
Revised 340B Rebate Model Pilot Program: What Covered Entities Need to Know for 2027
Starting January 1, 2027, the 340B landscape may shift following the Health Resources and Services Administration’s (HRSA) implementation of the revised 340B Rebate Model Pilot Program Pilot Program
-
Two-year Impact of a Targeted Workflow to Reengage Hard to Reach Patients Within a Health System Specialty Pharmacy
Posters
Two-year Impact of a Targeted Workflow to Reengage Hard to Reach Patients Within a Health System Specialty Pharmacy
This study assesses the impact of a structured approach to increase engagement with health system specialty pharmacy patients who were previously lost to follow up.
-
Digital Technology Intervention Impact on Staff Productivity in a Health System Specialty Pharmacy
Posters
Digital Technology Intervention Impact on Staff Productivity in a Health System Specialty Pharmacy
This study assesses the impact of technology-based and refill technician workflow interventions on health system specialty pharmacy staff productivity.
-
Pharmacist Interventions Associated with a Cardiac Amyloidosis Patient Management Program
Posters
Pharmacist Interventions Associated with a Cardiac Amyloidosis Patient Management Program
This study assesses the pharmacist impact within an ATTR-CM specialty program by characterizing documented interventions and associated outcomes.
-
Patient Perception of Treatment Experience Observed During Routine Specialty Pharmacy Interactions for ATTR-CM
Posters
Patient Perception of Treatment Experience Observed During Routine Specialty Pharmacy Interactions for ATTR-CM
This study assesses the patient perception of treatment experience observed during routine specialty pharmacy interactions among tafamidis-treated ATTR-CM patients.
-
Specialty Clinical Pharmacist Career Ladder to Support Growth, Retention, and Professional Advancement
Posters
Specialty Clinical Pharmacist Career Ladder to Support Growth, Retention, and Professional Advancement
This study shows how the Shields clinical pharmacist career ladder provides structured growth pathways and offers incentives that align with organizational and employee goals.
-
Health System Specialty Pharmacy Supports Access and Adherence for GLP-1 Receptor Agonists for Patients with Obesity
Posters
Health System Specialty Pharmacy Supports Access and Adherence for GLP-1 Receptor Agonists for Patients with Obesity
This study assesses the impact of an integrated health system specialty pharmacy model on GLP-1 RA access and adherence in adult patients with obesity.
-
Communities of Practice Program Impact on Clinical Roles, Knowledge, and Professional Development in Specialty Pharmacy
Posters
Communities of Practice Program Impact on Clinical Roles, Knowledge, and Professional Development in Specialty Pharmacy
This study describes the CoP program and demonstrates how it enriches the clinical roles supporting health system specialty pharmacies through disease knowledge and professional development.
-
Recombinant Human Growth Hormone Therapy Clinical Outcomes at an Integrated Health System Specialty Pharmacy
Posters
Recombinant Human Growth Hormone Therapy Clinical Outcomes at an Integrated Health System Specialty Pharmacy
This study assess the impact of a health system specialty pharmacy program on operational and clinical outcomes for patients on hGH.
-
Discontinuation of GLP-1 and GLP-1/GIP Receptor Agonists Among Adults with Type 2 Diabetes, Overweight or Obesity
Posters
Discontinuation of GLP-1 and GLP-1/GIP Receptor Agonists Among Adults with Type 2 Diabetes, Overweight or Obesity
This poster explores the ability of integrated health system specialty pharmacies to mitigate barriers faced by patients taking Glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
Ready to Put These Insights into Action?
Turn insight into impact with a partner that delivers proven results for health systems and patients.